Literature DB >> 23872551

Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus.

Nadia D Morgan1, Sheetal V Patel, Olga Dvorkina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23872551     DOI： 10.1097/RHU.0b013e31829d5e50

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  29 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Ciprofloxacin-Induced Syndrome of Inappropriate Antidiuretic Hormone; Anaphylactic Shock Due to Thrombolytic Administration; Hydroxychloroquine-Induced QT-Interval Prolongation; Complex Regional Pain Syndrome After Tetanus Toxoid Injection.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2014-04

3.  Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.

Authors:  Atiya R Faruqui; Denis Xavier; Sandhya K Kamat; Sujith J Chandy; Bikash Medhi; Raakhi K Tripathi; Yashashri C Shetty; John Michael Raj; Sandeep Kaushal; S Balakrishnan; Shubham Atal; Santanu K Tripathi; Dinesh K Badyal; Harihar Dikshit; Sukalyan Saha Roy; Niyati Trivedi; Suparna Chatterjee; Chetna Desai; C D Tripathi; Nirmala N Rege; Pooja Gupta; R Raveendran; Rajni Kaul; Nilima A Kshirsagar
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

Review 4.  Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Angelos Arfaras-Melainis; Andreas Tzoumas; Damianos G Kokkinidis; Maria Salgado Guerrero; Dimitrios Varrias; Xiaobo Xu; Luis Cerna; Ricardo Avendano; Cameron Kemal; Leonidas Palaiodimos; Robert T Faillace
Journal:  J Cardiovasc Dev Dis       Date:  2021-05-13

5.  Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine.

Authors:  John P O'Laughlin; Parag H Mehta; Brian C Wong
Journal:  Case Rep Cardiol       Date:  2016-07-12

6.  Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.

Authors:  Moussa Saleh; James Gabriels; David Chang; Beom Soo Kim; Amtul Mansoor; Eitezaz Mahmood; Parth Makker; Haisam Ismail; Bruce Goldner; Jonathan Willner; Stuart Beldner; Raman Mitra; Roy John; Jason Chinitz; Nicholas Skipitaris; Stavros Mountantonakis; Laurence M Epstein
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-04-29

7.  QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.

Authors:  Ehud Chorin; Lalit Wadhwani; Silvia Magnani; Matthew Dai; Eric Shulman; Charles Nadeau-Routhier; Robert Knotts; Roi Bar-Cohen; Edward Kogan; Chirag Barbhaiya; Anthony Aizer; Douglas Holmes; Scott Bernstein; Michael Spinelli; David S Park; Carugo Stefano; Larry A Chinitz; Lior Jankelson
Journal:  Heart Rhythm       Date:  2020-05-12       Impact factor: 6.343

8.  Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.

Authors:  Lu Ren; Wilson Xu; James L Overton; Shandong Yu; Nipavan Chiamvimonvat; Phung N Thai
Journal:  medRxiv       Date:  2020-05-08

9.  Pandemic COVID-19: Current status and challenges of antiviral therapies.

Authors:  Winglam Chan; Betsy He; Xiong Wang; Ming-Liang He
Journal:  Genes Dis       Date:  2020-07-07

Review 10.  Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.

Authors:  Marco Infante; Camillo Ricordi; Andrea Fabbri
Journal:  J Diabetes       Date:  2020-06-11       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.